PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $233,328 | +248.3% | 5,823 | +425.5% | 0.01% | +400.0% |
| Q2 2021 | $67,000 | -95.9% | 1,108 | -97.7% | 0.00% | -97.1% |
| Q1 2020 | $1,615,000 | -64.8% | 48,159 | -52.4% | 0.03% | -49.3% |
| Q4 2019 | $4,585,000 | -30.1% | 101,219 | -41.3% | 0.07% | -30.2% |
| Q3 2019 | $6,563,000 | -92.3% | 172,380 | -89.3% | 0.10% | -92.9% |
| Q1 2016 | $85,347,000 | – | 1,610,932 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |